BOTOX

Abbvie Corporation🇨🇦 Health Canada

Approval Id: 28362f439b5c4fa4
Drug Approval Canada Name: BOTOX
Product Name: BOTOX
Status: Marketed
Status Date: 2023-10-11
Original Market Date: 2023-10-11
Din: 02531585
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intramuscular
Schedule: Prescription , Schedule D
Ahfs: 12:20.20.24
Atc Original: M03AX01 BOTULINUM TOXIN
Atc Name: m 03 ax 01
Aig Number: 0151557004
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

ONABOTULINUMTOXINA

200 UNIT / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

28362f439b5c4fa4

Type

Standard